Research analysts at Deutsche Bank assumed coverage on shares of Clorox (NYSE:CLX) in a research report issued on Wednesday, The Fly reports. The brokerage set a “hold” rating on the stock.
A number of other analysts have also commented on the stock. Consumer Edge upgraded shares of Clorox from a “neutral” rating to an “outperform” rating in a research note on Friday, November 10th. Zacks Investment Research upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research note on Monday, November 6th. Morgan Stanley reduced their price target on shares of Clorox from $138.00 to $128.00 and set an “equal weight” rating for the company in a research note on Thursday, November 2nd. Jefferies Group reiterated a “hold” rating and issued a $132.00 price target on shares of Clorox in a research note on Wednesday, November 1st. Finally, Royal Bank of Canada reissued a “hold” rating and issued a $115.00 price objective on shares of Clorox in a report on Sunday, October 8th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $128.67.
Shares of Clorox (NYSE:CLX) traded up $1.46 during mid-day trading on Wednesday, hitting $146.61. 849,910 shares of the stock were exchanged, compared to its average volume of 817,212. Clorox has a 52-week low of $115.00 and a 52-week high of $147.38. The company has a market capitalization of $18,702.54, a price-to-earnings ratio of 26.14, a PEG ratio of 3.95 and a beta of 0.43. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77.
In related news, SVP Matthew T. Laszlo sold 20,051 shares of the firm’s stock in a transaction that occurred on Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total value of $2,615,853.46. Following the transaction, the senior vice president now owns 10,896 shares of the company’s stock, valued at $1,421,492.16. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Michael R. Costello sold 10,574 shares of Clorox stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the transaction, the senior vice president now directly owns 34,867 shares in the company, valued at approximately $4,742,260.67. The disclosure for this sale can be found here. Company insiders own 1.00% of the company’s stock.
A number of large investors have recently modified their holdings of the business. Jacobi Capital Management LLC lifted its holdings in Clorox by 0.3% during the second quarter. Jacobi Capital Management LLC now owns 1,286 shares of the company’s stock valued at $172,000 after purchasing an additional 4 shares in the last quarter. Valley National Advisers Inc. lifted its holdings in Clorox by 0.6% during the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock valued at $115,000 after purchasing an additional 5 shares in the last quarter. Bernzott Capital Advisors lifted its holdings in Clorox by 0.4% during the second quarter. Bernzott Capital Advisors now owns 1,607 shares of the company’s stock valued at $214,000 after purchasing an additional 7 shares in the last quarter. Financial Advisory Service Inc. lifted its holdings in Clorox by 0.3% during the second quarter. Financial Advisory Service Inc. now owns 4,012 shares of the company’s stock valued at $535,000 after purchasing an additional 12 shares in the last quarter. Finally, Moors & Cabot Inc. lifted its holdings in Clorox by 1.2% during the second quarter. Moors & Cabot Inc. now owns 2,557 shares of the company’s stock valued at $339,000 after purchasing an additional 30 shares in the last quarter. 73.42% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: “Clorox (CLX) Earns Hold Rating from Analysts at Deutsche Bank” was posted by American Banking and Market News and is owned by of American Banking and Market News. If you are viewing this article on another site, it was copied illegally and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/12/13/clorox-clx-earns-hold-rating-from-analysts-at-deutsche-bank.html.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
